Item 8.01 Other Events.
OnOctober 7, 2020 ,Kindred Biosciences, Inc. (the "Company") and its wholly-owned subsidiary,Centaur Biopharmaceutical, Inc. ("Centaur"), issued respective press releases announcing the Company has expanded its agreement with Vaxart, Inc. ("Vaxart") for the manufacture of Vaxart's oral vaccine for COVID-19 and other vaccine candidates, with manufacturing services to be performed by Centaur. Copies of the press releases by the Company and Centaur are attached to this Current Report on Form 8-K as Exhibits 99.1 and 99.2 and are incorporated herein by reference. Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release ofKindred Biosciences, Inc. issued onOctober 7, 2020 99.2 Press Release ofCentaur Biopharmaceutical, Inc. issued onOctober 7, 2020 104 Cover Page Interactive Data File (embedded
within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source